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1. Introduction 
y-Glutamyl transpeptidase, a membrane-bound 
enzyme, exhibits a number of catalytic activities: 
transfer of the y-glutamyl group of glutathione and 
other y-glutamyl compounds to amino acids, peptides, 
and to water [ 1,2]; a proteinase activity inherent o 
its light subunit [3]. The rat kidney.enzyme isa 
heterodimer (M, 68 000) of glycosylated subunits 
(heavy (H) and light (L) subunits, Mr 46 000 and 
22 000, respectively) [4,5]. The reaction mech~ism 
for the utilization of y-glutamyl compounds involves 
an intermediate formation of a covalent y-glutamyl- 
enzyme intermediate [6-91. y-Glutamyl analogs, 
such as DON, abolish the y-glutamyl transfer and pro- 
teinase activities of the enzyme by formation of a 
covalent adduct at the y-glutamyl site [3,6]. The 
residue alkylated by DON, and thus presumably the 
site at which y-glutamylation also occurs, is located 
on the L subunit. 
The ~ti-tumor drug, AT-l 25 [lo], a glutamine 
antagonist which ~activates a number of glutamine 
amidotr~sferases and ~utam~ases f 11,121, inhibits 
the y-glutamyl transpeptidase activity of kidney cells 
[ 131 and a human pancreatic arcinoma cell line [ 141. 
We report here the potent inhibition of purified rat 
kidney transpeptidase by AT- 125. The inactivation is 
accompanied by stoichiometric and covalent attach- 
ment of AT-125 to a residue in the y-glutamyl bind- 
Abbreviations: DON, 6diazo-S-oxo-L-norleucine; AT-1 25, 
L-(&, S~~~m~o-3~hIoro~,5dihydro-5-~~x~oleacetic 
acid; DTT, dithiothre~tol; SDS-PAGE, polya~y~ide gel 
electrophoresis in presence of sodium dodecylsulfate 
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ing domain of the enzyme. This residue, as in the case 
of DON, is located on the L subunit. The inhibition 
of the y-glutamyl transfer activity by AT-125 is quali- 
tatively similar to that observed with DON, although 
AT-125 is 20.fold more potent han DON. Interesting 
ly, however, AT-1 25 does not inactivate the proteinase 
activity of the L subunit whereas DON does, 
2. Materials and methods 
L-~-Glutamyl-~-nitro~~ide, glycylglycine and 
DTT were obtained from Sigma. Urea (ultra pure grade) 
was purchased from Schwarz/Mann. AT-125 and 
[2-3H]AT-12S (23 /&i/ymol) were generous gifts 
from Dr L. J. Hanka of Upjohn, Kalamazoo MI. Stock 
[3H]AT-125 was mixed with unlabeled AT-125 to 
give 3820 cpm/nmol. Rat kidney y-glutamyl trans- 
peptidase was purified as in [15] (spec. act. 750 pmol 
p-nitroaniline released . min-’ . mg protein-’ when 
assayed with 1 mM L-~-~utamyl-~-nitro~~de and 
20 mM Gly-Gly [3]). 
The effect of preincubation of tr~speptidase with 
DON and AT-125 on its activity was studied essen- 
tially as described for DON [6]. Affinity labeling of 
the enzyme with [3H]AT-125 was carried out as fol- 
lows: transpeptidase (1 mg/mlO.O5 M sodium phos- 
phate buffer (pH 7.5)) was incubated at 37°C for 1 h 
with 0.05 mM [3H] AT-l 25. Following extensive dial- 
ysis at 4°C against 0.01 M Tris-HCl buffer (pH S), 
the samples were analyzed for protein [ 161, residual 
transpeptidase activity, and bound radioactivity. Sub- 
unit localization of bound [3H]AT-125 was achieved 
by subjecting the labeled enzyme to SDS-PAGE (8% 
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gels, 0.1% SDS [4]). The subunits were localized by 
staining a gel with Coomassie blue R-250. A duplicate 
gel was sliced into 2 mm sections; each slice was incu- 
bated in a glass scintillation vial for 12 h at 37°C with 
10 ml toluene scintillation medium containing 0.6% 
PPO, 0.0075% POPOP, and 3% Protosol (New England 
Nuclear). The samples were then counted in a liquid 
scintillation counter. 
The proteinase activity of the light subunit of trans- 
peptidase [3] was determined as follows: transpep- 
tidase (1 O-l 5 pg) was incubated at 37” C in a solution 
(0.1 ml) containing 5 mM Tris-IICI (pH 8) 6 M urea 
and 5 mM DTT. The reaction was terminated by addi- 
tion of SDS (final cont. 1.5% (w/v)) and the samples 
placed in a boiling water bath for 5 min. The samples 
were then subjected to SDS-PAGE (10% gels, 0.1% 
SDS) and the gels stained with Coomassie blue R-250. 
The destained gels were scanned at 575 nm in a 
Coming 740 gel scanner; the relative amounts of the 
II and L subunits were determined by comparison 
with a scan obtained from an equivalent amount of 
enzyme subjected to SDS-PAGE without prior urea 
treatment. The proteinase activity is expressed as the 
percentage of I-I subunit degraded. 
3. Results 
Preincubation of the enzyme with AT-125 results 
in irreversible inactivation of transpeptidase (fig. 1, 
curve 1). Addition of L-serine plus borate (a combina- 
tion which forms a complex that mimics the transition 
state y-glutamyl-enzyme intermediate [7]) protects 
against inactivation by AT-I 25 (fig. 1, curve 2) where- 
as maleate (which stimulates hydrolysis of ~glutamyl 
substrates [8,17]) enhances the rate of inactivation 
-g-fold (fig. 1, curve 3). Acceptor substrates (Gly- 
Gly and L-methionine, 10 mM each) have no effect 
on inactivation rate. These results, which indicate that 
AT-125 inactivates transpeptidase by binding to the 
y-glutamyl site of the enzyme, are qualitatively similar 
to those previously reported for DON-mediated inac- 
tivation of transpeptidase (see [6]; also tig.1, curves 
4,5). However, at equimolar levels, AT-125 is -2O- 
fold more effective as an inhibitor than DON. Plot of 
the time required for 50% inactivation against the 
reciprocal of AT-1 25 concentration [ 181 yields an 
app. Ki value for AT-125 of 0.6 mM. The app. Ki 
value for DON, similarly derived, is 2 mM [6]. 
Complete inactivation of transpeptidase with [31j] - 
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Fig.1. Effect of AT-l 25 and DON on the activity of rat kidney 
y-glutamyl transpeptidase. The enzyme (5 ng) was incubated 
at 37°C in 0.2 ml 0.05 M phosphate buffer (pH 7.5) contain- 
ing 0.05 mM either AT-l 25 (curves l-3) or DON (curves 4,5) 
and other compounds as indicated below: (1) AT-125; (2) 
AT-125 plus 5 mM each of L-serine and sodium borate; (3) 
AT-125 plus 50 mM maleate; (4) DON; (5) DON plus 50 mM 
maleate. Aliquots (2 ~1) were assayed for residual transpep- 
tidase activity with 1 mM L-y-glutamyl-p-nitroanilide and 
20 mM Gly-Gly. 
AT-125 is accompanied with the covalent binding of 
close to 1 mol ‘H-labeled compound/mol enzyme 
(table l), and maximal binding is not affected by the 
presence of maleate. L-Serine plus borate decreases 
the extent of inactivation and the amount of binding 
of AT-125. Prior treatment of the enzyme with DON 
prevents subsequent binding of [ 311] AT- 125. SDS- 
PAGE of the [31i] AT-125~labeled nzyme reveals that 
covalent attachment of the [ 311] derivative occurs 
exclusively to the L subunit (not shown), as shown in 
[6] for DON. 
Treatment of transpeptidase with dissociating 
agents (e.g., urea) unmasks a proteinase activity inher- 
ent to the L subunit which preferentially and rapidly 
degrades the II subunit (fig.2B) [3]. Prior treatment 
of the enzyme with DON abolishes both the transpep- 
tidase activity and the proteinase activity (fig.2D); 
presence of serine plus borate during DON treatment 
prevents loss of not only the transpeptidase activity 
but also of the proteinase activity (fig.2E). Surprising- 
ly, however, AT-125, which like DON inactivates the 
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Table 1 
Binding of [“HI AT-l 25 to r-glutamyl transpeptidase 
Expt. Additions Incuba- Bound Residual 
tion AT-125 transpeptidase 
(mm) fmoljmol activity (%) 
enzyme) 
1 None 20 0.43 48 
2 None 60 0.92 2.6 
3 Maleate 20 0.93 <O.l 
4 L-Serine 
+ borate 20 0.12 8.5 
5 DON-treated 60 0.01 co.1 
The enzyme was treated with 0.05 mM [‘HI AT-l 25 in the 
absence or presence of 50 mM maleate or 5 mM each of 
Lserine and borate and then extensively dialyzed (section 2). 
Aliquots were then analyzed for protein, ‘H and residual 
transpeptidase activity. In expt. 5, the enzyme was first 
inactivated with DON as in fig.2 and then treated with [“HI- 
AT-1 25 
transpeptidase activity by covalently interacting with 
a residue in the y-glutamyl binding site, had no effect 
on the proteinase activity (fig.2C). Since the binding 
of AT-1 25 and DON to the enzyme is mutually exclu- 
sive, prior incubation with AT-125 (<O.l% residual 
transpept~dase activity) prevented the inactivation of 
the proteinase activity by subsequent DON treatment 
(fig.2F). The rate of degradation of the fi subunit of 
[3f-I]AT-125-treated transpeptidase, incubated in 6 M 
urea in presence of DTT (3 1,56,69 and 76% in 1.5, 
30,45 and 60 mm, respectively), was similar to that 
observed with untreated enzyme. It is of interest how- 
ever, that the radioactivity associated with the L chain 
(due to bound [31-I]AT-125) did not diminish during 
incubation of the enzyme in urea indicating that the 
affinity label was not lost and reinforcing our prior 
observations that incubation of the enzyme in urea 
results in preferential degradation of the I-I subunit, 
4. Discussion 
The potent inhibition of the y-glutamyl transfer 
activity of y-glutamyl transpeptidase by AT-125, an 
anti-tumor glutamine antagonist, is shown to be due 
to its covalent attachment to a residue in the y-glut- 
amyl binding, site of the enzyme. The effects of 
AT-125 resemble in several respects the actions of 
DON [6], another future analog. Thus, inactiva- 
tion by both is prevented by competitive inhibitors 
Fig.2. Effect of AT-125 and DON on the proteinase activity 
of yglutamyl transpeptidase. The enzyme (0.5 mg) was 
incubated at 37°C in 0.3 ml 0.05 M phosphate buffer (pH 
7.5) containing either 0.25 mM AT-125 or 2.5 mM DON and, 
where indicated, 5 mM L-serine plus 10 mM sodium borate. 
The samples were dialyzed extensively against 10 mM Tris- 
HCI buffer (pH 8) and then analyzed for protein and residual 
transpeptidase activity. The proteinase activity (as indicated 
by the decrease in H subunit) of the treated and untreated 
enzyme samples (12 rg each) was determined by incubating 
in a solution containing 6 M urea and 5 mM DTT at 37°C for 
30 mm (section 2), following which the samples were sub- 
jected to SDS-PAGE (10% gels; 0.1% SDS). The gels shown 
are as follows (treatment of the enzyme prior to proteinase 
assay is indicated and the residual transpeptidase activities 
(%) are shown in parentheses): (A) native enzyme applied 
directly to the gels; (B) proteinase activity of untreated 
enzyme; (C) AT-125treated (0.1%); (D) DON-treated (0.1%); 
(E) DON treatment in presence of L-serine plus borate (73%); 
(F) AT-125 followed by DON (<O.l%). H and L represent 
the heavy and light subunits of transpeptidase, respectivelv. 
of y-glutamyl substrates and enhanced markedly by 
maleate (a modulator of y-glutamyl transfer activities 
[8,17]). Both inhibitors are covalently attached to 
residues located on the L subunit of the enzyme. 
AT-125 is, however, 20-fold more potent than DON 
and also exhibits greater apparent affinity for the 
enzyme as reflected by the respective Ki values. 
Despite these similarities between the actions of 
AT-l 25 and DON there is a marked contrast in their 
effects on the proteinase activity of the L subunit. 
The proteinase activity, not seen in the native enzyme, 
is revealed upon treatment of the enzyme with pro- 
tein dissociating agents (e.g., urea, SDS) [3]. The E-I 
subunit is preferentially degraded. Prior treatment of 
the native enzyme with DON inhibits the proteinase 
activity whereas AT-125 treatment has no effect on 
this activity. Thus, although both analogs inhibit 
y-glutamyl transfer activities of the native enzyme by 
binding to the y-glutamyl site, is appears that they 
covalently modify different residues in this site. Pre- 
vious studies, based on the stability of the enzyme- 
173 
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DON adduct, suggest hat a hydroxyl residue of the 
enzyme is aIkylated by DON 171. Prehminary studies 
with the AT-125-enzyme adduct indicate that a group 
other than a hydroxyl group may be involved in the 
covalent attachment of AT-125 (S. J. G., unpubli~ed}. 
Further studies are required to elucidate the involve- 
ment of the various active center residues in the cata- 
lytic activities exhibited by transpeptidase. 
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